Intas Pharmaceuticals Ltd - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others. It also develops recombinant DNA protein (rDNA) products and plasma derived products for oncology, auto-immune, ophthalmology, nephrology, and plasma derived product based therapies. It has nine formulation manufacturing facilities and two active pharmaceutical ingredient (API) and intermediate facilities in India. The company markets its products globally through internal sales force and a network of distributors. Intas is headquartered in Ahmedabad, Gujarat, India.

Intas Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Intas Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Teva Pharma May Sell European Oncology and Pain Assets 13
Intas Pharma and Aurobindo Pharma May Acquire Europen Divisions from Teva Pharma 15
Teva Pharma Sells Assets and Operations of Actavis Generics in UK and Ireland to Accord Healthcare 16
Intas Pharma to Acquire Gujarat-based Biotechnology Unit of RPG Life Sciences for USD3.7 Million 18
Intas Pharma Acquires Hospital Business of Combino Pharm 19
Private Equity 20
Capital International Acquires 3% Stake in Intas Pharma from ChrysCapital for USD106 Million 20
Temasek Acquires 10.16% Stake in Intas Pharma for USD143 Million 21
ChrysCapital Acquires Additional 7.5% Stake In Intrys Phrama For US$56.1 Million 22
ChrysCapital Acquires Additional 2.53% Stake In Intas Pharma For US$56 Million 23
Partnerships 24
Albany Molecular Research Enters into Agreement with Grupo Ferrer and Accord Healthcare 24
Licensing Agreements 25
Intas Pharma Enters into Licensing Agreement with Iconovo 25
Phosphagenics Enters Into Licensing Agreement With Intas Pharma For Anti-Ageing Products 26
Mayne Pharma Group Enters Into Licensing Agreement With Intas Pharma For Injectable Products 27
Equity Offering 28
Intas Pharma Files Registration Statement For IPO To Raise Up To US$200 Million 28
Acquisition 29
Accord Healthcare Acquires Essential Pharma 29
Actavis Acquires Auden Mckenzie for USD458 Million 30
Intas Pharmaceuticals Ltd - Key Competitors 31
Intas Pharmaceuticals Ltd - Key Employees 32
Intas Pharmaceuticals Ltd - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables

List of Tables
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intas Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Intas Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Teva Pharma May Sell European Oncology and Pain Assets 13
Intas Pharma and Aurobindo Pharma May Acquire Europen Divisions from Teva Pharma 15
Teva Pharma Sells Assets and Operations of Actavis Generics in UK and Ireland to Accord Healthcare 16
Intas Pharma to Acquire Gujarat-based Biotechnology Unit of RPG Life Sciences for USD3.7 Million 18
Intas Pharma Acquires Hospital Business of Combino Pharm 19
Capital International Acquires 3% Stake in Intas Pharma from ChrysCapital for USD106 Million 20
Temasek Acquires 10.16% Stake in Intas Pharma for USD143 Million 21
ChrysCapital Acquires Additional 7.5% Stake In Intrys Phrama For US$56.1 Million 22
ChrysCapital Acquires Additional 2.53% Stake In Intas Pharma For US$56 Million 23
Albany Molecular Research Enters into Agreement with Grupo Ferrer and Accord Healthcare 24
Intas Pharma Enters into Licensing Agreement with Iconovo 25
Phosphagenics Enters Into Licensing Agreement With Intas Pharma For Anti-Ageing Products 26
Mayne Pharma Group Enters Into Licensing Agreement With Intas Pharma For Injectable Products 27
Intas Pharma Files Registration Statement For IPO To Raise Up To US$200 Million 28
Accord Healthcare Acquires Essential Pharma 29
Actavis Acquires Auden Mckenzie for USD458 Million 30
Intas Pharmaceuticals Ltd, Key Competitors 31
Intas Pharmaceuticals Ltd, Key Employees 32
Intas Pharmaceuticals Ltd, Other Locations 33
Intas Pharmaceuticals Ltd, Subsidiaries 34

List Of Figures

List of Figures
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Intas Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Cintas: Performance, Capabilities, Goals and Strategies in the Global Business Services Industry

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

Intas Pharmaceuticals Ltd - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers

USD 250 View Report

Galmed Pharmaceuticals Ltd (GLMD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Galmed Pharmaceuticals Ltd (Galmed Pharmaceuticals), a subsidiary of Galmed International Ltd, is a clinical-stage biopharmaceutical company. The company focuses on the development of therapeutics for the treatment of liver diseases.

USD 250 View Report

Kiniksa Pharmaceuticals Ltd (KNSA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kiniksa Pharmaceuticals Ltd (Kiniksa Pharmaceuticals) is a clinical-stage biopharmaceutical company focused on discovery, acquisition, development and commercialization of therapeutic medicines for the treatment of auto inflammatory and autoimmune diseases. Its

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available